Table 2.
univariate linear regression model initial levels and changes in serum levels of ICAM-1
| Variable | Initial Level | Changes in serum level | ||
|---|---|---|---|---|
| β (95% CI) | p | β (95% CI) | p | |
| Female vs male | -10.45 (-64.31; 43.41) | 0.697 | -9.34 (-25.05; 6.36) | 0.236 |
| Age | -0.82 ( -2.39; 0.76) | 0.301 | 0.20 ( -0.27; 0.67) | 0.394 |
| Hemoglobin | 3.92 ( -5.71; 13.54) | 0.415 | 0.27 ( -2.61; 3.15) | 0.850 |
| Leukocytes | -1.59 ( -3.71; 0.53) | 0.138 | -0.58 ( -1.20; 0.04) | 0.065 |
| Erythrocytes | 9.09 (-17.95; 36.13) | 0.500 | 1.73 ( -6.32; 9.78) | 0.666 |
| Platelets | -0.02 ( -0.18; 0.14) | 0.778 | -0.02 ( -0.07; 0.02) | 0.271 |
| Eosinophils | 1.21 (-10.27; 12.69) | 0.832 | -1.50 ( -4.52; 1.51) | 0.318 |
| Basophils | 29.71 (-50.28; 109.71) | 0.456 | 10.98 (-10.14; 32.11) | 0.298 |
| Stabs Neutrophils | 1.76 (-1.19; 4.71) | 0.233 | 1.44 (0.88; 2.00) | <0.001 |
| Segmented Neutrophils | -0.55 (-2.19; 1.09) | 0.503 | -0.70 (-1.07; -0.33) | 0.001 |
| Lymphocytes | -1.70 (-5.19; 1.80) | 0.332 | -0.28 (-1.21; 0.66) | 0.556 |
| Monocytes | 4.90 (-3.52; 13.32) | 0.245 | 0.27 (-2.02; 2.55) | 0.815 |
| NLR | 0.61(-5.45; 6.68) | 0.838 | -0.99 (-2.57; 0.59) | 0.212 |
| Sodium | 3.37(-0.08; 6.82) | 0.056 | 0.92 (0.01; 1.82) | 0.047 |
| Potassium | 0.34(-18.60; 19.28) | 0.971 | 0.39 (-4.58; 5.36) | 0.874 |
| Chloride | 2.28(-0.89; 5.44) | 0.153 | 0.53 (-0.31; 1.37) | 0.207 |
| SGOT | 0.17(-0.06; 0.41) | 0.140 | 0.01 (-0.05; 0.07) | 0.762 |
| SGPT | 1.34(-0.28; 2.96) | 0.102 | 0.01 (-0.40; 0.42) | 0.965 |
| Urea | -0.09(-0.55; 0.37) | 0.699 | -0.02 (-0.14; 0.10) | 0.722 |
| Creatinine | -2.68(-13.15; 7.80) | 0.606 | -1.02 (-3.56; 1.53) | 0.422 |
| COVID-19 | 87.94(35.98; 139.90) | 0.001 | -15.17 (-32.08; 1.74) | 0.077 |
CI, confidence interval; ICAM, intercellular adhesion molecule; SGOT, serum glutamic oxaloacetic transaminase; SGPT, serum glutamate-pyruvate transaminase; NLR, Neutrophil Lymphocyte Ratio